BITE Trademark

Trademark Overview


On Tuesday, December 26, 2000, a trademark application was filed for BITE with the United States Patent and Trademark Office. The USPTO has given the BITE trademark a serial number of 78040636. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, June 28, 2016. This trademark is owned by MICROMET AG. The BITE trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

[ Medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intra-peritoneal, intra-muscular and aerosol therapies ]

[ Human and veterinary services, namely, licensing of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases; licensing of technology for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples p...

Medical services; laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; human and veterinary services, namely, product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particu...
bite

General Information


Serial Number78040636
Word MarkBITE
Filing DateTuesday, December 26, 2000
Status800 - REGISTERED AND RENEWED
Status DateTuesday, June 28, 2016
Registration Number3068856
Registration DateTuesday, March 14, 2006
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 9, 2003

Trademark Statements


Goods and Services[ Medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intra-peritoneal, intra-muscular and aerosol therapies ]
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services[ Human and veterinary services, namely, licensing of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases; licensing of technology for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells ]
Goods and ServicesMedical services; laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; human and veterinary services, namely, product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, June 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, June 28, 2016
Primary Code035
First Use Anywhere DateWednesday, October 31, 2001
First Use In Commerce DateWednesday, October 31, 2001

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 10, 2001
Primary Code042
First Use Anywhere DateWednesday, October 31, 2001
First Use In Commerce DateWednesday, October 31, 2001

Trademark Owner History


Party NameAMGEN RESEARCH (MUNICH) GMBH
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressMUNICH 81477
DE

Party NameMICROMET AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address81477 Munchen
DE

Party NameMICROMET AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address81477 Munchen
DE

Party NameMICROMET AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address81477 Munchen
DE

Trademark Events


Event DateEvent Description
Thursday, February 14, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 17, 2001ASSIGNED TO EXAMINER
Wednesday, June 6, 2001NON-FINAL ACTION MAILED
Thursday, November 29, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 4, 2002EXAMINERS AMENDMENT MAILED
Tuesday, February 5, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 24, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 10, 2002PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, April 10, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 9, 2002PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, June 26, 2002NON-FINAL ACTION MAILED
Monday, October 21, 2002PAPER RECEIVED
Monday, October 21, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 6, 2003NON-FINAL ACTION MAILED
Thursday, May 22, 2003PAPER RECEIVED
Thursday, May 22, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 20, 2003NOTICE OF PUBLICATION
Monday, November 29, 2004SOU EXTENSION 2 FILED
Tuesday, September 9, 2003PUBLISHED FOR OPPOSITION
Monday, September 29, 2003PAPER RECEIVED
Tuesday, December 2, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 19, 2004SOU TEAS EXTENSION RECEIVED
Wednesday, May 19, 2004SOU EXTENSION 1 FILED
Friday, May 28, 2004SOU EXTENSION 1 GRANTED
Wednesday, May 26, 2004CASE FILE IN TICRS
Monday, November 29, 2004SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2004SOU EXTENSION 2 GRANTED
Wednesday, February 1, 2006ASSIGNED TO LIE
Wednesday, February 1, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, March 14, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, May 19, 2005SOU TEAS EXTENSION RECEIVED
Thursday, May 19, 2005SOU EXTENSION 3 FILED
Friday, June 3, 2005SOU EXTENSION 3 GRANTED
Friday, December 2, 2005USE AMENDMENT FILED
Tuesday, December 27, 2005STATEMENT OF USE PROCESSING COMPLETE
Monday, December 5, 2005PAPER RECEIVED
Tuesday, January 17, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 14, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 28, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, June 18, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 1, 2012TEAS SECTION 8 & 15 RECEIVED
Saturday, March 31, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, April 1, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, April 2, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, March 23, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 8, 2016TEAS SECTION 8 & 9 RECEIVED
Tuesday, June 28, 2016REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Tuesday, June 28, 2016REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Tuesday, June 28, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, June 28, 2016NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, April 29, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, March 14, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED